“…P35 is a pan caspase inhibitor, which inhibits caspases 1, 3, 6, 7, 8, and 10 while crmA selectively inhibits caspases 1 and 8 (Bump et al, 1995, Zhou et al, 1997. Using the HSV vector system and primary neuronal cultures, we have demonstrated the neuroprotective ability of p35 and crmA after excitotoxic stimuli (Roy et al, 2001, Roy et al, 2002, Roy and Sapolsky, 2003. In this study we further compare the protective effects of p35 and crmA.…”